Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients

Margherita Maioli, Maria Gnoli, Manila Boarini, Morena Tremosini, Anna Zambrano, Elena Pedrini, Marina Mordenti, Serena Corsini, Patrizia D'Eufemia, Paolo Versacci, Mauro Celli, Luca Sangiorgi

Research output: Contribution to journalArticle

Abstract

Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I-IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype-phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported "lethal clusters" were causative of OI types I-IV. Some discrepancies have been highlighted also considering the "50-55 nucleotides rule," as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalEuropean Journal of Human Genetics
DOIs
Publication statusE-pub ahead of print - Mar 18 2019

Fingerprint

Osteogenesis Imperfecta
Genetic Association Studies
Mutation
Dentinogenesis Imperfecta
Collagen
Inborn Genetic Diseases
Sclera
Collagen Type I
Connective Tissue
Serine
Nucleotides
Genotype
Phenotype

Cite this

Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. / Maioli, Margherita; Gnoli, Maria; Boarini, Manila; Tremosini, Morena; Zambrano, Anna; Pedrini, Elena; Mordenti, Marina; Corsini, Serena; D'Eufemia, Patrizia; Versacci, Paolo; Celli, Mauro; Sangiorgi, Luca.

In: European Journal of Human Genetics, 18.03.2019, p. 1-11.

Research output: Contribution to journalArticle

Maioli, Margherita ; Gnoli, Maria ; Boarini, Manila ; Tremosini, Morena ; Zambrano, Anna ; Pedrini, Elena ; Mordenti, Marina ; Corsini, Serena ; D'Eufemia, Patrizia ; Versacci, Paolo ; Celli, Mauro ; Sangiorgi, Luca. / Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients. In: European Journal of Human Genetics. 2019 ; pp. 1-11.
@article{9b7a93e88e2045e5a1ba3f5668ebcb06,
title = "Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients",
abstract = "Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90{\%} of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I-IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype-phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported {"}lethal clusters{"} were causative of OI types I-IV. Some discrepancies have been highlighted also considering the {"}50-55 nucleotides rule,{"} as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients.",
author = "Margherita Maioli and Maria Gnoli and Manila Boarini and Morena Tremosini and Anna Zambrano and Elena Pedrini and Marina Mordenti and Serena Corsini and Patrizia D'Eufemia and Paolo Versacci and Mauro Celli and Luca Sangiorgi",
year = "2019",
month = "3",
day = "18",
doi = "10.1038/s41431-019-0373-x",
language = "English",
pages = "1--11",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Genotype-phenotype correlation study in 364 osteogenesis imperfecta Italian patients

AU - Maioli, Margherita

AU - Gnoli, Maria

AU - Boarini, Manila

AU - Tremosini, Morena

AU - Zambrano, Anna

AU - Pedrini, Elena

AU - Mordenti, Marina

AU - Corsini, Serena

AU - D'Eufemia, Patrizia

AU - Versacci, Paolo

AU - Celli, Mauro

AU - Sangiorgi, Luca

PY - 2019/3/18

Y1 - 2019/3/18

N2 - Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I-IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype-phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported "lethal clusters" were causative of OI types I-IV. Some discrepancies have been highlighted also considering the "50-55 nucleotides rule," as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients.

AB - Osteogenesis imperfecta (OI) is a rare genetic disorder of the connective tissue and 90% of cases are due to dominant mutations in COL1A1 and COL1A2 genes. To increase OI disease knowledge and contribute to patient follow-up management, a homogeneous Italian cohort of 364 subjects affected by OI types I-IV was evaluated. The study population was composed of 262 OI type I, 24 type II, 39 type III, and 39 type IV patients. Three hundred and nine subjects had a type I collagen affecting function mutations (230 in α1(I) and 79 in α2(I)); no disease-causing changes were noticed in 55 patients. Compared with previous genotype-phenotype OI correlation studies, additional observations arose: a new effect for α1- and α2-serine substitutions has been pointed out and heart defects, never considered before, resulted associated to quantitative mutations (P = 0.043). Moreover, some different findings emerged if compared with previous literature; especially, focusing the attention on the lethal form, no association with specific collagen regions was found and most of variants localized in the previously reported "lethal clusters" were causative of OI types I-IV. Some discrepancies have been highlighted also considering the "50-55 nucleotides rule," as well as the relationship between specific collagen I mutated region and the presence of dentinogenesis imperfecta and/or blue sclera. Despite difficulties still present in defining clear rules to predict the clinical outcome in OI patients, this study provides new pieces for completing the puzzle, also thanks to the inclusion of clinical signs never considered before and to the large number of OI Italian patients.

U2 - 10.1038/s41431-019-0373-x

DO - 10.1038/s41431-019-0373-x

M3 - Article

C2 - 30886339

SP - 1

EP - 11

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

ER -